EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -86.0% | 1,903 | -75.4% | 0.00% | -100.0% |
| Q2 2022 | $50,000 | +78.6% | 7,735 | +1005.0% | 0.00% | +200.0% |
| Q1 2022 | $28,000 | +250.0% | 700 | +250.0% | 0.00% | – |
| Q4 2021 | $8,000 | -74.2% | 200 | -60.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -16.2% | 500 | +25.0% | 0.00% | -50.0% |
| Q1 2021 | $37,000 | -65.4% | 400 | -81.9% | 0.00% | -60.0% |
| Q4 2020 | $107,000 | +161.0% | 2,210 | +452.5% | 0.01% | +66.7% |
| Q3 2020 | $41,000 | – | 400 | +300.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 100 | -98.1% | 0.00% | – |
| Q4 2016 | $11,000 | -72.5% | 5,300 | -74.0% | 0.00% | -100.0% |
| Q3 2016 | $40,000 | -74.7% | 20,400 | -39.1% | 0.00% | -88.9% |
| Q2 2016 | $158,000 | – | 33,500 | +6600.0% | 0.01% | – |
| Q1 2016 | $0 | -100.0% | 500 | +150.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |